Can a simple algorithm replace a $4,000 cancer test?

NCT ID NCT04131933

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study looked at whether giving doctors a free online risk score (PREDICT 2.1) changes how often they order an expensive genetic test called Oncotype DX for early-stage breast cancer. Over 600 patients took part. The goal was to see if the algorithm could help doctors make better decisions about who really needs the costly test.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Grand River Hospital

    Kitchener, Ontario, N2G 1G3, Canada

  • Kingston Health Sciences Centre

    Kingston, Ontario, K7L 2V7, Canada

  • Markham Stouffville Hospital

    Markham, Ontario, L3P 7P3, Canada

  • Ottawa Hospital Research Institute

    Ottawa, Ontario, Canada

  • Thunder Bay Regional Health Sciences Centre

    Thunder Bay, Ontario, P7B 6V4, Canada

  • Windsor Regional Hospital

    Windsor, Ontario, N8W 1L9, Canada